SEC EDGAR Filing Information

Form DEF 14A -- Other definitive proxy statements

Period of Report: 2007-08-17
Filing Date Changed: 2007-08-17
Effectiveness Date: 2007-08-17
Documents: 3

SEC Accession No.
0000812796-07-000074
Filing date: 2007-08-17
Accepted: 2007-08-17 17:07:12

Table of submitted documents:

Seq	Type	Document	Size	Description
1	DEF 14A	proxydef14a082007.htm	491638	PROXY DEF14A
2	GRAPHIC	stocvkgraph2006.jpg	80104	2006 STOCK GRAPH
3	GRAPHIC	dorlogo1.jpg	3838	DORLOGO

		0000812796-07-000074.txt	609249	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-16929 | Film No.: 071065812
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131